How do regulatory T cells work?

Corthay A. · 2009

Read How do regulatory T cells work? by Corthay A. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2784904.txt.

Introduction

Corthay reviewed in 2009 how regulatory T cells work, the CD4 T cells charged with suppressing other T helper cells that might harm the body. Their proposed jobs include holding self-tolerance to prevent autoimmune disease, calming allergy and asthma, and protecting the fetus during pregnancy. Yet basic questions about these cells remain open, and the review defines them plainly.

Identifying regulatory cells is itself a problem. Every marker in current use, from CD25 to Foxp3, also appears on ordinary activated T cells, so none is truly specific. Their suppression switches on only for specific antigens, and their receptor patterns suggest they are usually not self-reactive. Even their status as a separate lineage is disputed, since ordinary helper subsets can also suppress. Some regulatory cells can even convert into effector cells in the body.

Catalog record

CREATORCorthay A.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE62 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2784904

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

How do Regulatory T Cells Work? By A Corthay Published in: Scandinavian Journal of Immunology DOI: 10.1111/j.1365-3083.2009.02308.x ABSTRACT CD4+ T cells are commonly divided into regulatory T (Treg) cells and conventional T helper (Th) cells. Th cells control adaptive immunity against pathogens and cancer by activating other effector immune cells. Treg cells are defined as CD4+ T cells in charge of suppressing potentially deleterious activities of Th cells. This review briefly summarizes the current knowledge in the Treg field and defines some key questions that remain to be answered. Suggested functions for Treg cells include: prevention of autoimmune diseases by maintaining self-tolerance; suppression of allergy, asthma and pathogen-induced immunopathology; feto-maternal tolerance; and oral tolerance. Identification of Treg cells remains problematic, because accumulating evidence suggests that all the presently-used Treg markers (CD25, CTLA-4, GITR, LAG-3, CD127 and Foxp3) represent general T-cell activation markers, rather than being truly Treg-specific. Treg-cell activation is antigen-specific, which implies that suppressive activities of Treg cells are antigen-dependent. It has been proposed that Treg cells would be self-reactive, but extensive TCR repertoire analysis suggests that self-reactivity may be the exception rather than the rule. The classification of Treg cells as a separate lineage remains controversial because the ability to suppress is not an exclusive Treg property. Suppressive activities attributed to Treg cells may in reality, at least in some experimental settings, be exerted by conventional Th cell subsets, such as Th1, Th2, Th17 and T follicular (Tfh) cells. Recent reports have also demonstrated that Foxp3+ Treg cells may differentiate in vivo into conventional effector Th cells, with or without concomitant downregulation of Foxp3. INTRODUCTION The concept of suppression mediated by T cells is nearly as old as the discovery of T cells as a separate lineage of lymphocytes. Already in the early 1970s, it was proposed that suppressor T cells would be capable of inhibiting other T cells, and thereby mediate immunological tolerance and self/non-self discrimination [1–3]. Suppressor T cells, which were characterized by expression of the CD8 (Lyt-2) cell surface marker, have been the topic of more than 1000 scientific publications. However, the existence of suppressor T cells as a distinct lineage of T cells has been very controversial [4]. In fact, the concept of suppressor T cells was largely abandoned by the end of the 1980s, essentially because of the poor characterization of the cells and the lack of specific markers [4, 5]. In the mid-1990s, a new subpopulation of suppressor T cells was proposed which expressed CD4 and which was named regulatory T (Treg) cells [5]. Accordingly, CD4+ T cells are now commonly divided into two distinct lineages: Treg cells and conventional T helper (Th) cells. Conventional Th cells control the adaptive immunity by activating, in an antigen-specific fashion, other effector cells such as CD8+ cytotoxic T cells, B cells and macrophages. Treg cells are defined as T cells in charge of suppressing potentially deleterious activities of Th cells. Treg cells represent nowadays a large field of research and a long list of Treg-associated suppressive mechanisms have been reported [6, 7]. However, many central aspects of Treg cell biology remain obscure and hotly debated [8–18]. The present review will focus on CD4+ Treg cells and will not discuss the older literature on the functionally-related suppressor T cells. My main objective is to briefly summarize the current knowledge in the Treg field and to define some key questions which remain to be answered. I also would like to encourage all readers interested in immunologic controversies to read and send contributions to the discussion forum of the Scandinavian Journal of Immunology [14–23]. SEVEN KEY QUESTIONS ABOUT TREG CELLS THAT REMAIN TO BE ANSWERED What are the functions of Treg cells? The primary function of Treg cells was originally defined as prevention of autoimmune diseases by maintaining self-tolerance [24]. Over the years, several additional functions have been suggested and it will be important to clarify what Treg cells actually do in the immune system. Presently, at least 10 non-exclusive functions have been proposed for Treg cells (Fig. 1A): [Figure: Five key questions about Treg cells. (A) What are the functions of Treg cells? (B) What molecular markers can be used to distinguish Treg cells from conventional Th cells? (C) Do Treg cells recognize self or non-self? (D) Do Treg cells represent a distinct lineage of CD4+ T cells? (E) How do Treg cells know which Th cell to suppress? In other words, how do Treg cells discriminate between the bad (i.e. self-reactive) Th cells, which should be suppressed, and the good (i.e. virus-specific) Th cells which should not?] - Prevention of autoimmune diseases by establishing and maintaining immunologic self-tolerance [24–27]. - Suppression of allergy and asthma [28–30]. - Induction of tolerance against dietary antigens, i.e. oral tolerance [31–34]. - Induction of maternal tolerance to the fetus [35]. - Suppression of pathogen-induced immunopathology [36–38]. - Regulation of the effector class of the immune response [10, 11]. - Suppression of T-cell activation triggered by weak stimuli [39]. - Feedback control of the magnitude of the immune response by effector Th cells [13, 40]. - Protection of commensal bacteria from elimination by the immune system [14]. - Prevention of T cells that have been stimulated by their true high-affinity agonist ligand from killing cells that only express low-affinity T-cell receptor (TCR) ligands such as the self peptide-major histocompatibility complex (MHC) molecule that positively selected the T cell [16]. It will be important to establish whether Treg cells are indeed performing all the above-listed functions. A related question is whether distinct subsets of Treg cells are responsible for the various suppressive activities. How to identify Treg cells? Molecular markers are essential tools for defining and for analyzing a subpopulation of immune cells. The collapse of the suppressor T cells at the end of the 1980s was largely due to the failure to define specific markers for these cells [4]. The most widely used markers for Treg cells are (Fig. 1B): - CD25 [24, 41]. - cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) [42, 43]. - glucocorticoid-induced tumour necrosis factor receptor family-related gene (GITR) [44]. - lymphocyte activation gene-3 (LAG-3) [45]. - CD127 [46, 47]. - forkhead/winged-helix transcription factor box P3 (Foxp3) [48–50]. Unfortunately, accumulating evidence suggests that the above-listed markers are not strictly Treg-specific. Upon activation, all T cells express CD25, the α-chain of the interleukin-2 (IL-2) receptor [51–53], IL-2 being a T-cell growth factor which is important for T-cell clonal expansion. CTLA-4 is a negative regulator of T-cell activation, which is upregulated on all CD4+ and CD8+ T cells, 2–3 days following activation [52–54]. Similarly, the expression of GITR [52, 53, 55] and LAG-3 [56, 57] is induced in T cells upon activation. It has been suggested that CD127, the α chain of the IL-7 receptor, could be used to discriminate between CD127low Treg cells and CD127high conventional Th cells in humans [46, 47]. However, it has been recently reported that most CD4+ T cells downregulate CD127 upon activation [53, 58]. Furthermore, loss of CD127 is a characteristic feature of T follicular helper (Tfh) cells, which provide help for B cells, in human tonsils [59]. It has been reported that naïve, CD25-negative mouse CD4+ T cells do not upregulate Foxp3 when

Read the complete text